Jul 23 2008
Early Signal of Breast Cancer, Beware!
Most women are familiar with mammography as our “gold standard” for detection of breast cancer. However, there are other tools that women can add to their arsenal. One of the most effective tools for the detection of breast cancer is in self-examination (BSE). However, BSE is most effective when women are properly trained in the procedure, then a follow-up annual clinical breast examinations (CBE) by their doctors. In 2000 a University of Toronto study, approximately 20000 women were selected for breast cancer with BSE and annual CBE, and 20000 have been screened by BSE and mammography.
After more than 10 years, BSE and annual CBE reported 610 cases of invasive breast cancer and 105 deaths. In BSE and mammography group, there were 622 cases of invasive breast cancer and 107 deaths. Undoubtedly, the first line of defense against breast cancer begins diligently BSE. Other tools are available for women include AMAS (anti-antibody malignan screen) and the nuclear test NMP matrix proteins) test. Both are blood tests that measure a certain protein in blood may indicate that the cancer. The AMAS test has been around for several years while NMP test was not available until very recently. Clinical trials are ongoing in this area.
Another tool that May detect an issue early digital infrared thermal imaging or DITI. In 1982, the FDA approved thermography as a supplementary tool for the detection of breast cancer. DITI measures heat emitted by the body and an accuracy of 1/100th of one degree. DITI examines the physiology, NOT structure. As such, DITI can monitor the health of the breasts over time and alert a patient or doctor to a development problem, maybe before capital can be seen on X-ray or palpation clinic. There is no test as the density of the breast. DITI is a non-invasive test that does not emit radiation.
The unique characteristics of cancer DITI detect breast cancer at an earlier stage of growth. That the cancer develops, he built his own blood, which is then taken into account increased heat in this particular region of the breast. DITI has a specificity of 83%, reflecting a problem in the early stages of its development rather than an advanced stage of cancer mammography. An abnormal thermogram brings to 10 times higher risk for cancer and a persistently abnormal thermogram door 22 times greater risk for cancer.
Clinical research studies continue to support the role of thermography as a tool to support breast cancer screening and the only tool that measures health breast over time. There are now more than 800 publications on more than 30 thousand women in clinical trials. A recent research published in the American Journal of Radiology in 2003 showed that thermography a 99% sensitivity in identifying breast cancer with examinations and unique point of view limited. The researchers concluded that negative thermogram is powerful evidence that cancer is not present.
Related PRO!
No responses yet
